Creative Medical Technology Holdings Inc (CELZ)
4.44
+0.04
(+0.91%)
USD |
NASDAQ |
May 24, 16:00
4.44
0.00 (0.00%)
After-Hours: 19:54
Creative Medical Technology Holdings Cash from Operations (Quarterly): -0.8969M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.8969M |
| December 31, 2023 | -1.895M |
| September 30, 2023 | -1.304M |
| June 30, 2023 | -0.9867M |
| March 31, 2023 | -3.842M |
| December 31, 2022 | -3.591M |
| September 30, 2022 | -0.8733M |
| June 30, 2022 | -1.756M |
| March 31, 2022 | -1.577M |
| December 31, 2021 | -1.161M |
| September 30, 2021 | -0.3908M |
| June 30, 2021 | -0.2221M |
| March 31, 2021 | -0.4415M |
| December 31, 2020 | 0.057M |
| September 30, 2020 | -0.174M |
| June 30, 2020 | -0.1222M |
| March 31, 2020 | -0.1953M |
| December 31, 2019 | -0.2524M |
| September 30, 2019 | -0.3583M |
| June 30, 2019 | -0.3294M |
| March 31, 2019 | -0.273M |
| December 31, 2018 | -0.2956M |
| September 30, 2018 | -0.3469M |
| June 30, 2018 | -0.2448M |
| March 31, 2018 | -0.1649M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.1227M |
| September 30, 2017 | -0.2737M |
| June 30, 2017 | -0.2695M |
| March 31, 2017 | -0.2237M |
| December 31, 2016 | -0.1854M |
| September 30, 2016 | -0.1209M |
| June 30, 2016 | -0.1033M |
| March 31, 2016 | -0.0357M |
| December 31, 2015 | -0.0019M |
| September 30, 2015 | -0.0024M |
| June 30, 2015 | -0.0049M |
| March 31, 2015 | -0.0054M |
| December 31, 2014 | -0.0053M |
| September 30, 2014 | -0.0027M |
| June 30, 2014 | -0.0053M |
| March 31, 2014 | -0.0041M |
| December 31, 2013 | -0.0043M |
| September 30, 2013 | -0.0037M |
| June 30, 2013 | -0.0059M |
| March 31, 2013 | -0.009M |
| December 31, 2012 | -0.0032M |
| September 30, 2012 | -0.004M |
| June 30, 2012 | -0.0026M |
| March 31, 2012 | -0.007M |
| December 31, 2011 | -0.0001M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.842M
Minimum
Mar 2023
0.057M
Maximum
Dec 2020
-1.016M
Average
-0.6574M
Median
Cash from Operations (Quarterly) Benchmarks
| Avid Bioservices Inc | 3.687M |
| Viking Therapeutics Inc | -6.134M |
| Avinger Inc | -4.734M |
| Aptevo Therapeutics Inc | -6.651M |
| Absci Corp | -17.86M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.520M |
| Cash from Financing (Quarterly) | -0.0828M |
| Free Cash Flow | -5.083M |
| Free Cash Flow Per Share (Quarterly) | -0.631 |
| Free Cash Flow Yield | -81.13% |